IL-6 activates the MAPK/ERK1/2 pathway, leading to overexpression of the MMP9, which contributes to extracellular matrix remodeling and fibrosis, processes involved in adverse ventricular remodeling and heart failure following myocardial infarction [27]. This evidence concerns the gene IL6 and myocardial infarction.